Kim Joo-Hee, Yee Jeong, Chang Byung-Chul, Gwak Hye-Sun
Institute of Pharmaceutical Science and Technology, College of Pharmacy, Ajou University, 206 Worldcup-ro, Yeongtong-gu, Suwon 16499, Korea.
Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Korea.
Pharmaceuticals (Basel). 2021 Aug 22;14(8):824. doi: 10.3390/ph14080824.
This study aimed to investigate the effects of genetic variants and haplotypes in the renin-angiotensin system (RAS) on the risk of warfarin-induced bleeding complications at therapeutic international normalized ratios (INRs).
Four single nucleotide polymorphisms (SNPs) of , two SNPs of , three SNPs of , four SNPs of , and one SNP of , in addition to and variants, were investigated. We utilized logistic regression and several machine learning methods for bleeding prediction.
The study included 142 patients, among whom 21 experienced bleeding complications. We identified a haplotype, H2 (TCG), carrying three SNPs of (rs1800764, rs4341, and rs4353), which showed a significant relation with bleeding complications. After adjusting covariates, patients with H2/H2 experienced a 0.12-fold (95% CI 0.02-0.99) higher risk of bleeding complications than the others. In addition, G allele carriers of rs5050 and A allele carriers of rs2640543 had 5.0- (95% CI 1.8-14.1) and 3.2-fold (95% CI 1.1-8.9) increased risk of bleeding complications compared with the TT genotype and GG genotype carriers, respectively. The AUROC values (mean, 95% CI) across 10 random iterations using five-fold cross-validated multivariate logistic regression, elastic net, random forest, support vector machine (SVM)-linear kernel, and SVM-radial kernel models were 0.732 (0.694-0.771), 0.741 (0.612-0.870), 0.723 (0.589-0.857), 0.673 (0.517-0.828), and 0.680 (0.528-0.832), respectively. The highest quartile group (≥75th percentile) of weighted risk score had approximately 12.0 times (95% CI 3.1-46.7) increased risk of bleeding, compared to the 25-75th percentile group, respectively.
This study demonstrated that RAS-related polymorphisms, including the H2 haplotype of the gene, could affect bleeding complications during warfarin treatment for patients with mechanical heart valves. Our results could be used to develop individually tailored intervention strategies to prevent warfarin-induced bleeding.
本研究旨在探讨肾素-血管紧张素系统(RAS)中的基因变异和单倍型对治疗性国际标准化比值(INR)时华法林所致出血并发症风险的影响。
除了 和 变异外,还研究了 的4个单核苷酸多态性(SNP)、 的2个SNP、 的3个SNP、 的4个SNP以及 的1个SNP。我们采用逻辑回归和几种机器学习方法进行出血预测。
该研究纳入了142例患者,其中21例出现了出血并发症。我们鉴定出一种携带 三个SNP(rs1800764、rs4341和rs4353)的单倍型H2(TCG),其与出血并发症显著相关。调整协变量后,携带H2/H2的患者发生出血并发症的风险比其他患者高0.12倍(95%CI 0.02 - 0.99)。此外,rs5050的G等位基因携带者和rs2640543的A等位基因携带者发生出血并发症的风险分别比TT基因型和GG基因型携带者增加5.0倍(95%CI 1.8 - 14.1)和3.2倍(95%CI 1.1 - 8.9)。使用五折交叉验证的多变量逻辑回归、弹性网络、随机森林、支持向量机(SVM)-线性核和SVM-径向核模型在10次随机迭代中的受试者工作特征曲线下面积(AUROC)值(均值,95%CI)分别为0.732(0.694 - 0.771)、0.741(0.612 - 0.870)、0.723(0.589 - 0.857)、0.673(0.517 - 0.828)和0.680(0.528 - 0.832)。加权风险评分的最高四分位数组(≥第75百分位数)与第25 - 75百分位数组相比,出血风险增加约12.0倍(95%CI 3.1 - 46.7)。
本研究表明,包括 基因的H2单倍型在内的RAS相关多态性可能影响机械心脏瓣膜患者华法林治疗期间的出血并发症。我们的结果可用于制定个性化的干预策略以预防华法林所致出血。